Cyclo Therapeutics, Inc.
6 clinical trials · Sponsor
◉ Watch Cyclo Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| A 6-Month Study to Evaluate the Safety & Potential Efficacy of Trappsol Cyclo in Patients With Early Alzheimer's Disease (NCT05607615) | Cyclo Therapeutics, Inc. | 2022-09-23 |
| Phase 3 Study to Evaluate Intravenous Trappsol(R) Cyclo(TM) in Pediatric and Adult Patients With Niemann-Pick Disease Type C1 (NCT04860960) | Cyclo Therapeutics, Inc. | 2021-07-20 |
| Open-Label Study of Long-Term Safety and Efficacy of Intravenous Trappsol Cyclo (HPβCD) in Niemann-Pick Disease Type C (NCT03893071) | Cyclo Therapeutics, Inc. | 2019-05-23 |
| Study of the Pharmacokinetics of Trappsol and Effects on Potential Biomarkers of Niemann-Pick C1 (NPC1) (NCT02939547) | Cyclo Therapeutics, Inc. | 2017-10-11 |
Track Cyclo Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.